Pricing Log in Create free account
Friday 6 November 2026 Export SUPN’s income statement to Excel — free account

Indivior Pharmaceuticals Inc.

SUPN Healthcare Drug Manufacturers Specialty & Generic

Indivior Pharmaceuticals Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.2 billion, up 4.29% from fiscal 2024.

Revenue
+13.4%
EPS
+241.5%
Free cash flow
+240.7%
Total debt
+51.6%

Quarter to September 2026, against a year earlier

28.21 0.06 +0.21%
Market cap
$5.6B
P/E
7.6×
Fwd P/E
9.5×
Dividend yield
0.00%
F-score
4/9
Altman Z
3.28
Beneish M
−1.52
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Indivior Pharmaceuticals Inc. (SUPN) Current ratio

Alert me on Current ratio

Indivior Pharmaceuticals Inc.'s current ratio at the end of the quarter to 30 September 2026 was 0.6×, down 0.1× from fiscal 2025 (0.7×). Over the past ten years it has ranged from 0.7× (fiscal 2025) to 2.0× (fiscal 2020) — the current reading is the lowest in ten years. That is below the Drug Manufacturers Specialty & Generic industry median of 2.4× and below the Healthcare sector median of 3.1×.

Current ratio, annual

Embed this chart

Annual newest first

Period Current ratio Change
FY2025 0.7× (20.30%)
FY2024 0.9× (8.80%)
FY2023 1.0× (20.57%)
FY2022 1.2× (31.21%)
FY2021 1.8× (9.37%)
FY2020 2.0× 8.11%
FY2019 1.8× 12.81%
FY2018 1.6× 13.27%
FY2017 1.4× 49.23%
FY2016 1.0× (19.61%)

Quarterly newest first

Period Current ratio Change
Sep 2026 0.6× (26.39%)
Jun 2026 0.8× (2.44%)
Mar 2026 0.9× 20.03%
Dec 2025 0.7× (25.34%)
42 more quarters

Against its own ten years

Low 0.7× High 2.0×
Ten-year median 1.2×
Current reading's percentile 9

Current ratio against peers

Company Current ratio
AMLX Amylyx Pharmaceuticals, Inc. compare 12.1×
KNSA Kiniksa Pharmaceuticals International, plc compare 3.9×
LNTH Lantheus Holdings, Inc. compare 3.2×
ALKS Alkermes plc compare 2.4×
LQDA Liquidia Corporation compare 2.3×
RDY Dr. Reddy's Laboratories Ltd compare 1.9×
AMRX AMNEAL PHARMACEUTICALS, INC. compare 1.9×
HIMS Hims & Hers Health, Inc. compare 0.9×
SUPN Indivior Pharmaceuticals Inc. 0.6×
Drug Manufacturers Specialty & Generic industry median 2.4×
Healthcare sector median 3.1×
Market median 1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

More on SUPN